Back to Search
JOSEPH PALMISANO, MD
MD
Nephrology Physician
NPI: 1487651816Individual
Specialties, Licenses & Credentials
Critical Care Medicine (Internal Medicine) Physician
Internal Medicine — Critical Care Medicine
Code: 207RC0200X
223989(CT)
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
023989(CT)
Research & Publications (20)
The effect of L-arginine and creatine on vascular function and homocysteine metabolism.
PMID 19651674·Vasc Med·2009
2-rct
Twenty-year follow-up: an unusual case of nephropathy of antiphospholipid syndrome.
PMID 19395460·Lupus·2009
5-case
The alignment of information systems with organizational objectives and strategies in health care.
PMID 19307148·Int J Med Inform·2009
8-other
Predictors of habitual snoring and obstructive sleep apnea risk in patients with asthma.
PMID 18849401·Chest·2009
8-other
Perineural administration of dexmedetomidine in combination with bupivacaine enhances sensory and motor blockade in sciatic nerve block without inducing neurotoxicity in rat.
PMID 18719449·Anesthesiology·2008
7-preclinical
Flow-induced arterial remodeling relates to endothelial function in the human forearm.
PMID 18541736·Circulation·2008
8-other
Relation of cumulative weight burden to vascular endothelial dysfunction in obesity.
PMID 18157973·Am J Cardiol·2008
8-other
Reversible posterior leukoencephalopathy syndrome (RPLS) in a patient with systemic lupus erythematosus (SLE) and lupus nephritis.
PMID 17517793·Nephrol Dial Transplant·2007
5-case
Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different races and ethnicities: a substudy of the Ezetimibe add-on to statin for effectiveness trial.
PMID 16970214·Mayo Clin Proc·2006
4-observational
The effect of simvastatin on triglyceride-rich lipoproteins in patients with type 2 diabetic dyslipidemia: a SILHOUETTE trial sub-study.
PMID 16466606·Curr Med Res Opin·2006
4-observational
Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).
PMID 15695129·Am J Cardiol·2005
3-trial
LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD.
PMID 16369229·MedGenMed·2005
4-observational
Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment.
PMID 16297596·Genomics·2005
4-observational
Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials.
PMID 16004682·Curr Med Res Opin·2005
4-observational
A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
PMID 15887425·Mayo Clin Proc·2005
3-trial
Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study.
PMID 15864235·Am Heart J·2005
3-trial
Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
PMID 16503317·Am J Geriatr Pharmacother·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 263 FARMINGTON AVE
FARMINGTON, CT 06030 - Phone
- (860) 679-2160
Quick Facts
- NPI
- 1487651816
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile